After Braze, Could Klaviyo Be Big Tech’s Next Billion-Dollar Bet?
Salesforce’s $5.66 billion Braze deal puts Klaviyo in focus as investors weigh the value of customer-engagement software.
Stocks · News reference
Piper Sandler analyst Billy Fitzsimmons downgrades Braze (NASDAQ:BRZE) from Overweight to Neutral and raises the price target from $30 to $47.5.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Salesforce’s $5.66 billion Braze deal puts Klaviyo in focus as investors weigh the value of customer-engagement software.
Oppenheimer analyst Brian Schwartz downgrades Braze (NASDAQ:BRZE) from Outperform to Perform.
Stifel analyst Parker Lane downgrades Braze (NASDAQ:BRZE) from Buy to Hold and raises the price target from $35 to $47.5.